Cambridge Investment Research Advisors Inc. reduced its position in shares of MSCI Inc. (NYSE:MSCI – Get Rating) by 6.8% in the 4th quarter, HoldingsChannel reports. The firm owned 1,380 shares of the technology company’s stock after selling 100 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in MSCI were worth $642,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Accurate Wealth Management LLC purchased a new position in MSCI in the fourth quarter valued at about $27,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new position in MSCI in the fourth quarter valued at about $28,000. MV Capital Management Inc. increased its holdings in MSCI by 79.2% in the fourth quarter. MV Capital Management Inc. now owns 95 shares of the technology company’s stock valued at $44,000 after buying an additional 42 shares in the last quarter. Guardian Wealth Advisors LLC purchased a new position in MSCI in the third quarter valued at about $48,000. Finally, Carolinas Wealth Consulting LLC increased its holdings in MSCI by 37.5% in the first quarter. Carolinas Wealth Consulting LLC now owns 99 shares of the technology company’s stock valued at $50,000 after buying an additional 27 shares in the last quarter. 88.18% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
MSCI has been the subject of a number of research analyst reports. UBS Group dropped their target price on shares of MSCI from $611.00 to $570.00 in a report on Wednesday, April 26th. Oppenheimer increased their price target on shares of MSCI from $575.00 to $600.00 and gave the company an “outperform” rating in a research report on Tuesday, April 4th. SpectralCast reiterated a “maintains” rating on shares of MSCI in a research report on Wednesday, April 26th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of MSCI from $560.00 to $522.00 in a research report on Wednesday, April 26th. Finally, Raymond James increased their price target on shares of MSCI from $549.00 to $574.00 and gave the company an “outperform” rating in a research report on Thursday, April 13th. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $567.50.
MSCI Stock Performance
MSCI (NYSE:MSCI – Get Rating) last announced its quarterly earnings results on Tuesday, April 25th. The technology company reported $3.14 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.23. The company had revenue of $592.20 million for the quarter, compared to analyst estimates of $593.92 million. MSCI had a net margin of 38.62% and a negative return on equity of 93.49%. MSCI’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the business earned $2.98 EPS. As a group, equities analysts predict that MSCI Inc. will post 12.92 EPS for the current year.
MSCI Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 31st. Shareholders of record on Friday, May 12th will be issued a $1.38 dividend. The ex-dividend date is Thursday, May 11th. This represents a $5.52 dividend on an annualized basis and a dividend yield of 1.20%. MSCI’s dividend payout ratio (DPR) is presently 50.60%.
MSCI, Inc engages in the provision of investment decision support tools including indices, portfolio risk and performance analytics and corporate governance products and services. It operates through the following segments: Index, Analytics, ESG and Climate, and All Other-Private Assets. The Index segment focuses on the investment process, including developing indexed financial products.
- Get a free copy of the StockNews.com research report on MSCI (MSCI)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Want to see what other hedge funds are holding MSCI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MSCI Inc. (NYSE:MSCI – Get Rating).
Receive News & Ratings for MSCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSCI and related companies with MarketBeat.com's FREE daily email newsletter.